3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Weight Loss
6
Breast Neoplasms
6
Obesity
5
Motor Activity
5
Polycystic Ovary Syndrome
4
Neoplasms
4
Colorectal Neoplasms
3
Prostatic Neoplasms
2
Overweight
2
Multiple Endocrine Neoplasia Type 1
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Body Weight Changes
2
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Sexual Dysfunction, Physiological
1
Polyps
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Menstruation Disturbances
1
Malnutrition
1
Lung Neoplasms
1
Inflammation
1
Infertility
1
Hypercholesterolemia
1
Gastrointestinal Neoplasms
1
Diabetes Mellitus, Type 2
1
Carcinoma, Intraductal, Noninfiltrating
1
Interventions
Gemcitabine
79
Cisplatin
56
pembrolizumab
32
Paclitaxel
28
Carboplatin
24
Docetaxel
19
Radiotherapy
17
Mitomycin
16
Doxorubicin
15
atezolizumab
14
BCG Vaccine
14
Nivolumab
13
Cystectomy
13
Filgrastim
11
vinflunine
10
Methotrexate
10
Vinblastine
9
Fluorouracil
9
5-aminolevulinic acid hexyl ester
9
Sunitinib
7
Early Intervention, Educational
7
durvalumab
6
avelumab
6
Taxes
6
Methods
6
Cystoscopy
6
Albumin-Bound Paclitaxel
6
enfortumab vedotin
5
Trastuzumab
5
Surveys and Questionnaires
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Urinary Bladder Neoplasms
×
Diet
×
Clear all
NCT06002269
2025-07-20
BOOST
University of Utah
Phase NA
Completed
8 enrolled